Ildong Holdings Co Ltd Asset Resilience Ratio

Latest as of June 2026: 1.15%

Ildong Holdings Co Ltd asset resilience ratio. Ildong Holdings Co Ltd (000230) has an Asset Resilience Ratio of 1.15% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000230 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩9.09 Billion
≈ $6.16 Million USD Cash + Short-term Investments

Total Assets

₩790.85 Billion
≈ $535.95 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Ildong Holdings Co Ltd (1999–2025)

Asset resilience ratio of Ildong Holdings Co Ltd from 1999 to 2025. This chart shows how Ildong Holdings Co Ltd's Asset Resilience Ratio has changed over time. Read 000230 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Ildong Holdings Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Ildong Holdings Co Ltd total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩9.09 Billion 1.15%
Total Liquid Assets ₩9.09 Billion 1.15%

Asset Resilience Insights

  • Limited Liquidity: Ildong Holdings Co Ltd maintains only 1.15% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Ildong Holdings Co Ltd Industry Peers by Asset Resilience Ratio

Compare Ildong Holdings Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211
Drug Manufacturers - Specialty & Generic 11.84%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Bide Pharmatech Co. Ltd. A
SHG:688073
Drug Manufacturers - Specialty & Generic 9.46%
Jianmin Pharmaceutical Group Co Ltd
SHG:600976
Drug Manufacturers - Specialty & Generic 20.61%
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
Drug Manufacturers - Specialty & Generic 30.38%
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
Drug Manufacturers - Specialty & Generic 0.42%

Ildong Holdings Co Ltd Asset Resilience Ratio by Year (1999–2025)

Ildong Holdings Co Ltd asset resilience ratio by year from 1999 to 2025. The table below shows the annual Asset Resilience Ratio data for Ildong Holdings Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.15% ₩1.20 Billion
≈ $814.19K
₩802.86 Billion
≈ $544.09 Million
-1.64pp
2024-12-31 1.79% ₩15.28 Billion
≈ $10.35 Million
₩854.70 Billion
≈ $579.22 Million
-1.78pp
2023-12-31 3.57% ₩31.29 Billion
≈ $21.21 Million
₩877.00 Billion
≈ $594.33 Million
-0.77pp
2022-12-31 4.34% ₩37.42 Billion
≈ $25.36 Million
₩862.55 Billion
≈ $584.54 Million
+1.49pp
2021-12-31 2.84% ₩26.19 Billion
≈ $17.75 Million
₩920.76 Billion
≈ $623.99 Million
+2.21pp
2020-12-31 0.64% ₩5.09 Billion
≈ $3.45 Million
₩799.40 Billion
≈ $541.74 Million
+0.23pp
2019-12-31 0.41% ₩3.30 Billion
≈ $2.23 Million
₩805.63 Billion
≈ $545.96 Million
-1.28pp
2018-12-31 1.69% ₩4.49 Billion
≈ $3.04 Million
₩265.47 Billion
≈ $179.90 Million
+0.75pp
2017-12-31 0.94% ₩2.59 Billion
≈ $1.76 Million
₩274.84 Billion
≈ $186.25 Million
-1.55pp
2016-12-31 2.49% ₩5.09 Billion
≈ $3.45 Million
₩204.09 Billion
≈ $138.31 Million
+1.93pp
2015-12-31 0.56% ₩3.98 Billion
≈ $2.69 Million
₩705.64 Billion
≈ $478.20 Million
+0.16pp
2014-12-31 0.40% ₩2.48 Billion
≈ $1.68 Million
₩620.35 Billion
≈ $420.40 Million
-0.03pp
2013-12-31 0.43% ₩2.68 Billion
≈ $1.82 Million
₩628.21 Billion
≈ $425.73 Million
-0.19pp
2012-12-31 0.62% ₩3.35 Billion
≈ $2.27 Million
₩541.71 Billion
≈ $367.11 Million
-0.43pp
2011-12-31 1.05% ₩5.35 Billion
≈ $3.63 Million
₩511.65 Billion
≈ $346.74 Million
-2.64pp
2010-12-31 3.68% ₩19.57 Billion
≈ $13.27 Million
₩531.23 Billion
≈ $360.01 Million
+2.68pp
2009-12-31 1.00% ₩4.96 Billion
≈ $3.36 Million
₩495.53 Billion
≈ $335.82 Million
-0.34pp
2008-12-31 1.34% ₩5.43 Billion
≈ $3.68 Million
₩404.79 Billion
≈ $274.32 Million
+0.48pp
2007-12-31 0.86% ₩2.90 Billion
≈ $1.96 Million
₩336.03 Billion
≈ $227.73 Million
-0.07pp
2006-12-31 0.93% ₩2.64 Billion
≈ $1.79 Million
₩283.77 Billion
≈ $192.31 Million
+0.57pp
2005-12-31 0.36% ₩941.26 Million
≈ $637.88K
₩258.07 Billion
≈ $174.89 Million
-0.09pp
2004-12-31 0.45% ₩1.05 Billion
≈ $709.94K
₩232.19 Billion
≈ $157.35 Million
-0.30pp
2003-12-31 0.75% ₩1.65 Billion
≈ $1.12 Million
₩218.82 Billion
≈ $148.29 Million
+0.20pp
2002-12-31 0.56% ₩1.09 Billion
≈ $741.62K
₩195.90 Billion
≈ $132.76 Million
-0.14pp
2001-12-31 0.70% ₩1.27 Billion
≈ $863.51K
₩183.11 Billion
≈ $124.09 Million
-0.21pp
2000-12-31 0.91% ₩1.70 Billion
≈ $1.15 Million
₩187.75 Billion
≈ $127.23 Million
+0.78pp
1999-12-31 0.12% ₩234.02 Million
≈ $158.59K
₩188.81 Billion
≈ $127.96 Million
--
pp = percentage points

About Ildong Holdings Co Ltd

KO:000230 Korea Drug Manufacturers - Specialty & Generic
Market Cap
$43.17 Million
₩63.70 Billion KRW
Market Cap Rank
#22240 Global
#1402 in Korea
Share Price
₩5520.00
Change (1 day)
-2.99%
52-Week Range
₩5520.00 - ₩15810.00
All Time High
₩51720.73
About

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the… Read more